Corlanor Tablet, Film Coated
Product Images NDC 55513-800

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Corlanor (NDC 55513-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Chemical Structure Of Ivabradine (Corlanor 01)

FDA Label Image

Figure 2. Impact Of Coadministered Drugs On The Pharmacokinetics Of Corlanor (Corlanor 02)

This text seems to be a list of medications and their recommended usage in the presence of other medication or substances. It includes information on strong and moderate inhibitors, inducers, and other medications, as well as PK measures and recommendations for dosage adjustments. Some medications are listed as contraindicated, and others are recommended to be avoided or to have no dose adjustment.*

FDA Label Image

Figure 3. Shift: Time To First Event Of Primary Composite Endpoint (Corlanor 03)

This appears to be a table with data related to heart failure (HF), but it is not clear what the variables mean. Therefore, it is not possible to generate a useful description.*

FDA Label Image

Figure 4. Effect Of Treatment On Primary Composite Endpoint In Subgroups (Corlanor 04)

FDA Label Image

Ndc 55513-800-80amgen®corlanor ®(ivabradine) Tablets5 mgeach Tablet Contains 5 mg Ivabradine Equivalent To 5.39 mg Ivabradine As Hydrochloride.oral Use.store At 25°c, Excursions Permitted To 15°c (30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France)

FDA Label Image

Ndc 55513-810-80amgen®corlanor ®(ivabradine) Tablets7.5 mgeach Tablet Contains 7.5 mg Ivabradine Equivalent To 8.085 mg Ivabradine As Hydrochloride.oral Use.store At 25°c, Excursions Permitted To 15°c (30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France)

This text is describing the different parts of a syringe, including the markings on the syringe, the plunger stopper, and the plunger itself.*

FDA Label Image

Corlanor 07

FDA Label Image

Corlanor 08

The text suggests that the volume of an ampule is 5m. However, it is not clear if this represents a specific unit of measurement (e.g., milliliters, microliters, etc.) or if there is additional context missing. Therefore, it is recommended to seek further information or clarification to fully understand the meaning of the text.*

FDA Label Image

Corlanor 09

Cortanar is a medication in ampule form with a volume of 5mL.*

FDA Label Image

Corlanor 0a

FDA Label Image

Corlanor 0b

FDA Label Image

Corlanor 0c

FDA Label Image

Corlanor 0d

FDA Label Image

Corlanor 0e

FDA Label Image

Corlanor 0f

FDA Label Image

Corlanor 10

FDA Label Image

Corlanor 11

FDA Label Image

Corlanor 12

FDA Label Image

Corlanor 13

The text is a product description for Corlanor - a medication produced by Amgen Inc. Each tablet contains 5 mg of ivabradine hydrochloride and is for oral use. It is advised to be stored at room temperature and kept out of reach of children. The enclosed medication guide should be dispensed to each patient. The text includes information on the recommended dosage, patent information, and copyright statement.*

FDA Label Image

Corlanor 14

This is a medication description for Amgen's Corlanor tablets. Each tablet contains 7.5 mg of ivabradine (equivalent to 108.085 mg of wabradine as hydrochloride) for oral use. It is recommended to be stored at 25°C and kept out of sight and reach of children. The enclosed Medication Guide is to be dispensed to each patient. The recommended dosage is provided in the prescribing information.*

FDA Label Image

Corlanor 15

This is a medication called Corlanor, with the active ingredient vabradine in 5mg/5mL oral solution form. It should be dispensed with both a medicine cup and sterile oral solution. It needs to be stored at a temperature between 15°C to 30°C and protected from light by storing it in a foil pouch. A medication guide needs to be dispensed to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.